Annals Of Oncology

Journal Title：Annals Of Oncology

Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.

Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

《肿瘤学年鉴》是欧洲肿瘤医学学会和日本肿瘤医学学会的期刊，提供快速、高效的同行评审出版物，内容涉及创新癌症治疗或与肿瘤学和精准医学相关的转化工作。

主要关注点包括：全身抗癌治疗（特别关注分子靶向药物和新型免疫疗法）、随机试验（包括阴性试验）、顶级指南以及目前作为个性化医疗关键组成部分出现的新兴领域，如分子病理学、生物信息学、现代统计学和生物技术。如果放射治疗、外科和儿科手稿与上述领域之一有明显的互动或具有范式转变，则可以考虑。

Annals Of Oncology创刊于1990年，由Oxford University Press出版商出版，收稿方向涵盖医学 - 肿瘤学全领域，在行业领域中学术影响力很大，属于TOP期刊，国际一流期刊，关注度和专业度非常高，所以对原创文章要求创新性很高，过审难度很高，如果您有志于TOP期刊，建议关注此刊。平均审稿速度 很快,2-3周 ，影响因子指数56.7，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。